Neola Medical

Bifogade filer

Neola Medical invites to presentation of the Q4-report 2025

Kurs

-5,66%

Likviditet

0,02 MSEK

Prenumeration

Kalender

	Est. tid*
2026-11-18	19:00	Kvartalsrapport 2026-Q3
2026-08-20	19:00	Kvartalsrapport 2026-Q2
2026-05-19	19:00	Kvartalsrapport 2026-Q1
2026-02-12	07:50	Bokslutskommuniké 2025
2025-11-05	-	Kvartalsrapport 2025-Q3
2025-08-22	-	Kvartalsrapport 2025-Q2
2025-05-22	-	X-dag ordinarie utdelning NEOLA 0.00 SEK
2025-05-21	-	Årsstämma
2025-05-21	-	Kvartalsrapport 2025-Q1
2025-02-12	-	Bokslutskommuniké 2024
2024-11-06	-	Kvartalsrapport 2024-Q3
2024-08-15	-	Kvartalsrapport 2024-Q2
2024-05-23	-	X-dag ordinarie utdelning NEOLA 0.00 SEK
2024-05-22	-	Årsstämma
2024-05-22	-	Kvartalsrapport 2024-Q1
2024-02-14	-	Bokslutskommuniké 2023
2023-12-29	-	Extra Bolagsstämma 2023
2023-11-09	-	Kvartalsrapport 2023-Q3
2023-08-15	-	Kvartalsrapport 2023-Q2
2023-05-19	-	X-dag ordinarie utdelning NEOLA 0.00 SEK
2023-05-17	-	Årsstämma
2023-05-17	-	Kvartalsrapport 2023-Q1
2023-02-14	-	Bokslutskommuniké 2022
2022-11-10	-	Kvartalsrapport 2022-Q3
2022-09-27	-	Extra Bolagsstämma 2022
2022-08-16	-	Kvartalsrapport 2022-Q2
2022-05-20	-	X-dag ordinarie utdelning NEOLA 0.00 SEK
2022-05-19	-	Årsstämma
2022-05-19	-	Kvartalsrapport 2022-Q1
2022-02-15	-	Bokslutskommuniké 2021
2021-11-09	-	Kvartalsrapport 2021-Q3
2021-09-14	-	Extra Bolagsstämma 2021
2021-08-17	-	Kvartalsrapport 2021-Q2
2021-05-21	-	X-dag ordinarie utdelning NEOLA 0.00 SEK
2021-05-20	-	Årsstämma
2021-05-20	-	Kvartalsrapport 2021-Q1
2021-02-16	-	Bokslutskommuniké 2020
2020-11-11	-	Kvartalsrapport 2020-Q3

Beskrivning

Land	Sverige
Lista	First North Stockholm
Sektor	Hälsovård
Industri	Medicinteknik

Neola Medical är verksamt inom medicinteknik. Bolaget är inriktade mot neonatalvården där de utvecklar medicinteknisk utrustning. Exempel på produkter som bolaget tillhandahåller till sjukvården inkluderar teknisk övervakning och uppföljning av lungkapaciteten hos tidigt födda spädbarn. Utöver huvudprodukten erbjuds kringprodukter och engångsartiklar. Störst verksamhet återfinns inom den nordiska marknaden. Neola Medical grundades 2016 och har huvudkontor i Sverige.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Neola Medical invites to presentation of the Q4-report 2025

2026-02-05 08:00:00

Neola Medical AB (publ) invites to a live presentation of the Q4-report of 2025, Thursday the 12th of February 2026 at 11:00 CET (11.00). The presentation will be held online hosted by Investor Studios. The Q4-report will be published the same morning.

Neola Medical publishes the Q4-report in the morning the 12th of February 2026. We hereby invite investors, analysts, and journalists to a live report presentation hosted by Investor Studios Thursday the 12th of February 2026 at 11:00 CET (11.00). The report will be presented by CEO Hanna Sjöström and CFO David Folkesson. Following the presentation, there will be a Q&A, where viewers have the opportunity to ask questions directly in the live chat.

Watch the presentation here: https://youtube.com/live/-_0FXFp8uXM

For further questions after the presentation, contact CFO David Folkesson through below contact details.

The report and report presentation will be available at Neola Medical’s website:
https://www.neolamedical.com/investors/rapporter-och-finansiell-kalender/

About Neola Medical
Neola Medical AB (publ) develops an innovative medical technology device for non-invasive, continuous lung monitoring and real-time alerts of potentially life-threatening lung complications in preterm born babies. By enabling instant detection, the technology aims to support earlier intervention, improve clinical decision-making, enhance long-term outcomes, and ultimately contribute to saving lives. The patented, cutting-edge technology was developed at Lund University in Sweden and is based on a spectroscopic method that measures changes in lung volume and oxygen gas concentration. Neola Medical builds on Sweden’s longstanding legacy of medical technology innovation and contributions to global health care. Neola Medical was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Neola Medical

Bifogade filer

Kurs -5,66%

Likviditet 0,02 MSEK